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BSO   Bilateral salpingo-oophorectomy 
FSH                      Follicle stimulating hormone 
LH                         Luteinising hormone 
HDL                     High density lipoproteins 
WHI                     Women‟s Health Initiative 
CEE                      Combined equine oestrogen 
ACOG                 American college of Obstetrics and Gynaecology 
RCOG                 Royal College of Obstetrics and Gynaecology 
RANZOG     Royal Australian and New Zealand College of Obstetrics and 
Gynaecology 
HRT                     Hormone replacement therapy 
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1. To identify local practice of prophylactic oophorectomy at the time of hysterectomy. 
2.  To identify which conditions would favour ovarian preservation versus those 
conditions that would support oophorectomy. 
3. To identify which guidelines gynaecologists, registrars and medical officers practice. 
4. To assess the need for local guidelines on prophylactic oophorectomy when it is 
performed at the time of hysterectomy for benign disease. 
5. To assess if differences in practices exist between different groups (public, private 
consultants, senior registrars, medical officers, male and females).  
METHODOLOGY 
A comprehensive literature search was made using internet facilities namely PubMed, 
Medline sources as well as recent articles in the University of KwaZulu Natal library.  An 
anonymous structured questionnaire was drawn up. The questionnaire (Appendix C) analysed 
age, gender, years of experience and whether prophylactic oophorectomy was opposed or 
proposed and which guidelines doctors used. The questionnaire also asked if there was a need 
for local guidelines. A statistician was consulted to calculate the relevant sample required. 
Ethical approval (Appendix A) was obtained from the ethics committee of the University of 
KwaZulu Natal. The questionnaire was distributed at the SASOG (South African Society for 
Obstetricians and Gynaecologists) 2012 conference. This is a national meeting attended by 
gynaecologists, registrars and medical - officers interested in obstetrics and gynaecology. 
Permission was first sort from the SASOG chairman prior to distribution of the questionnaire 
at the conference. At this meeting the questionnaire was distributed to all delegates to 
complete. SPSS version 19 was used to analyse the data. 
RESULTS 
One hundred and eighty five participants took part in this questionnaire based study. The 
mean (range) age of the participants was 46 ± 8.2 (range: 28-75) years.  The participants 
included specialists (n=147), registrars (n=35) and medical officers (n=3). The mean (SD) 
age of the specialists was 47.9 ± 14.2 years and the mean (range) number of months since 
being qualified as a specialist was 16 (1-146) months The mean (SD) age of the registrars 
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was 51.6 ± 14.7 years and the mean (range) number of years in training 3 (1-5) years. The 
mean (SD) age of the medical officers was 48.3 ± 2.9 years.  There was no difference in age 
between the participants (p=0.3). The age groups of the participants were as follows: 20-30 
(n=6; 3%); 31- 40 (n= 60; 32%; 41-50 (n=58; 31%); 51-60 (n=42; 23%) and >60 (n=19; 
10%). One hundred and twelve (71%) of participants were male and the remaining 73 (39%) 
were females.  Eighty eight (48%) were practicing in private, 71 (38%) were practicing in the 
public sector while 36 (14%) were practicing in both private and public sector. 
Among the participants there were 147 (79%) specialists, 35 (19%) registrars and 3 (2%) 
were medical officers. The mean (SD + range) age at which specialists, registrars and medical 
officers  recommend patients to have prophylactic oophorectomy following hysterectomy for 
benign conditions was 52.18  ±4.7 (35-65); 54.49±5.3 and 55 ±3.9 years respectively. There 
was no difference between specialists, registrars and medical officers with regards to age at 
which they recommend patients to have prophylactic oophorectomy following hysterectomy 
for benign conditions (p=0.45). Family history of ovarian, breast and colon cancer (94%) was 
the commonest factor followed by patient choice (48%), presence of ovarian cysts (45%), 
presence of endometriosis (37%), presence of peri-menopausal symptoms (35%), follicle 
stimulating hormone > 10 (17%) and other reasons (10%) were factors other than age 
influencing the decision of specialists, registrars and medical officers when performing 
prophylactic oophorectomy for benign disease, at the time of hysterectomy. 
 
All the participants were aware of both local and international guidelines, namely American 
College of Obstetrics and Gynaecology (ACOG), Royal College of Obstetrics and 
Gynaecology (RCOG) and Royal Australian and New Zealand College of Obstetrics and 
Gynaecology (RANZCOG) were well known to the participants. Seventy six (41%) of the 
participants did not use any guidelines but used the age of the patient as well as a familial 
history of cancer as a guide to decide about surgery. Sixty nine (38%) were using 
international guidelines.  Sixteen (9%) used departmental guidelines while 19 (10%) used 
their experience to decide. One hundred and fifty nine (85%) indicated that there is a need for 






Seventy six (41%) of the participants did not use any guidelines but used a history of cancer 
in the family and the age of the patient as a guide to decide about surgery. Sixty nine (38%) 
were using international guidelines.  Sixteen (9%) used departmental guidelines while 19 
(10%) used their experience to decide.  
Factors that influenced specialists, medical officers and registrars to opt for bilateral 
oophorectomy, together with hysterectomy included familial history of breast, ovarian and 
colon cancer (94%) followed by patients choice (48%), presence of ovarian cysts (45%), 
presence of endometriosis (37%), presence of peri-menopausal symptoms (35%), follicle 
stimulating hormone > 10 (17%) and other reasons (10%). 
 There was no difference between specialists, registrars and medical officers with regards to 
age at which they recommended patients to have prophylactic oophorectomy following 
hysterectomy for benign conditions. As evident by the responses received in the 
questionnaire the majority of doctors (85%) felt that there was a need for guidelines to be set 
out in order to direct obstetricians and gynaecologists in making uniform decisions and to 
prevent unnecessary surgery. 
This study was unable to adequately assess the difference in practice between the different 











Chapter One – Introduction 
1.1 Background and Literature 
Bilateral oophorectomy is a procedure used electively in order to prevent ovarian and breast 
cancer in high risk women. This procedure is advocated in women regarded as having a 
higher potential for the development of breast, colon or ovarian cancer. There are few 
guidelines that stipulate exact criteria for oophorectomy at the time of surgery, especially in 
women with no familial risk for ovarian, breast and colon cancer. Kauff et al, indicated that 
when bilateral oophorectomy is performed in patients who have a familial predisposition to 
the disease there is a lower risk of breast cancer 
[1]
. Women who undergo bilateral 
oophorectomy prior to onset of menopause lose their cyclic ovarian production of oestrogen 
and thus undergo a surgical menopause which results in many lifestyle changes. Hormone 
replacement therapy is thus advocated in these women in order to prevent subsequent 
decrease in sexual functioning, vasomotor symptoms, atherosclerosis, cardiac disease and 
bone changes. 
Hormone replacement has been given to peri-menopausal and postmenopausal females to 
prevent the onset of osteoporosis and help alleviate climacteric symptoms. It has been found 
to prevent fractures and also increase bone density however the WHI study found that in 
older postmenopausal women using 0,625mg/day of conjugated equine oestrogens, there was 
a higher risk of developing blood clots. The oestrogen-plus-progestin sub-study of the WHI 
study reported a significant risk of stroke, pulmonary emboli, invasive breast cancer, 
myocardial infarction and DVT in postmenopausal females 50 years or older as well as a 
significant risk of dementia in postmenopausal females greater than 65 years of age using 




The three main controversies surrounding prophylactic oophorectomy are: 
1. Should all females with a low risk for ovarian cancer be offered bilateral 
oophorectomy? 
2. Should total hysterectomy accompany prophylactic oophorectomy when performed 
electively in high risk women? 
3. What is the ideal age to perform prophylactic oophorectomy in high risk women? 
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A prospective cohort study from the Nurse‟s Health Study illustrated the degree of risk 
reduction of ovarian cancer when hysterectomy was performed together with bilateral 
salpingo- oophorectomy in the general population. The study included 29.380 women were 
hysterectomy was performed for non-malignant gynaecological disease, the average age was 
43-47 years and the patients were followed for 24 years. The study showed that women with 
oophorectomy had significant reductions in ovarian cancer incidence (2 versus 42 cases per 
100,000 person – years; HR 0.04, 95% CI 0.01-0.09) and ovarian cancer mortality (1 versus 
14 deaths per 100,000 person- years;   HR 0.06, 95% CI 0.02-0.21) as compared with patients 
with ovarian conservation 
[3]
. 
This risk reduction was similar irrespective of the age at which hysterectomy was performed. 
The Women‟s Health Initiative Observational Study showed similar results, it included 
25,448 patients where hysterectomy was performed for benign disease. Majority of women 
involved in the study were 49yrs or younger and it was found that the number needed to treat, 
in order to prevent one case of ovarian cancer was 323
[2]
. Thoughtful consideration should be 
given to the younger females undergoing pelvic surgery for gynaecological conditions as 
prophylactic oophorectomy might not eliminate the patients risk for the development of intra-
abdominal carcinomas example primary peritoneal carcinomas. 
Gynaecologists have been plagued on whether to proceed with bilateral oophorectomy 
together with hysterectomy for benign gynaecological conditions. As yet there are still no 
protocols available to guide us in this decision making. In the 1987 Technical Bulletin, the 
American College of Obstetrics and Gynaecology (ACOG) recommended discussing 




The Royal Australian and New Zealand College of Obstetricians and Gynaecologists 
published a statement as follows: “when hysterectomy is being performed in patients younger 
than 65 years for benign gynaecological disease, careful consideration should be made when 
bilateral oophorectomy is being performed.” Alison H Brand (2009) undertook a study in 
Australia and found that there was no agreement amongst gynaecology consultants and 
registrars in recommending the appropriate  age at which to routinely  perform prophylactic 
oophorectomies in females undergoing hysterectomy for non-malignant disease, except that ,  





There is considerable variation in the decision for prophylactic oophorectomy as there are a 
few reliable studies to evaluate risks and benefits of the procedure. The benefits of 
oophorectomy are discussed as follows: 
1.2 Benefits of Oophorectomy 
1.2.1 Ovarian cancer prevention 
 Bilateral salpingo-oophorectomy was frequently performed at hysterectomies to decrease 
future risk of ovarian cancer and further reoperations for ovarian pathologies. It is estimated 
that a woman's lifetime risk of subsequent development of ovarian cancer is 1.4% in the 
United States of America however this risk estimation is dependent on ethnicity, number of 
pregnancies and the use other oral contraceptive pill
[6] 
. The decision for prevention of 
ovarian cancer by performing BSO is controversial. Some physicians believe that 
approximately 1000 newly diagnosed patients with ovarian cancer can be prevented in the 
United States each year if bilateral oophorectomy was performed together with hysterectomy 
for women  older than 40 years
[7]
.  In contrast to the beliefs of these physicians, there are 
others who have indicated that the rate of ovarian cancer after hysterectomy is low, with 2 
women per 1000 experiencing a subsequent ovarian cancer after hysterectomy alone
[8]
.  
Ovarian cancer is a fatal condition that is often overshadowed by the magnitude of breast and 
cervical cancer. Risk factors for the disease include: women who are nulliparous and infertile, 
women who have undergone conservative surgery for stage 1 ovarian cancer, a history of 
familial ovarian cancer and hereditary ovarian cancer syndrome. The factors that reduce the 
risk of ovarian cancer development are: Early use of oral contraceptive pills, first full term 
pregnancy at an early age, breast feeding and tubal ligation. 
Considering the poor compliance of the oral contraceptive and low accuracy of screening 
tests in early recognition of ovarian cancer prophylactic oophorectomy is justified in peril and 
postmenopausal women. In most countries the decision for prophylactic oophorectomies lies 
with the gynaecologist, hence the decision for our study arose from the need for proper 
guidelines to identify which patients were considered as appropriate for the necessary 
intervention. The American College of Obstetrics and Gynaecology have made the following 
recommendations: (The following recommendation is based on limited or inconsistent 
scientific evidence) Bilateral sapling-oophorectomy should be offered to women with 





(The following recommendations are based primarily on consensus and expert opinion) 
Females with a family history which indicates BRCA mutations should have genetic 
counselling and BRCA testing. Females, who are at a higher risk of ovarian cancer, should 
have bilateral salpingo-oophorectomy with careful inspection of the peritoneal cavity, 




Premenopausal women who are low risk with no genetic history of ovarian cancer should 
strongly be considered for ovarian preservation. Postmenopausal women have a risk of 
developing ovarian cancer therefore, oophorectomy and hysterectomy should be considered 
for these women. Women who are at higher risk for reoperation include those with pelvic 
inflammatory disease, endometriosis and chronic pelvic pain ; therefore careful consideration 
should be made in terms of  risk of subsequent surgery if the ovaries are preserved  against 




1.2.2 Reduced risk of future ovarian surgery 
Women who have retained their ovaries are at risk for reoperation due to ovarian pathologies. 
The reported reoperation rate on retained ovaries ranges from 0.9 to 5.2% 
[9].
 Ovarian residual 
syndrome appears in some women after hysterectomy in which one or both ovaries are 
conserved and is characterized by lower backache, lower abdominal pain and deep 
dyspareunia. This syndrome was more commonly seen in patients who underwent, 
hysterectomies at a younger age, this is thought to be due to the long postoperative ovarian 
function which results in greater opportunity for ovarian pathology.   
Oophorectomies may play a role in preventing pelvic pain and ovarian cyst formation. In 
postmenopausal women with ovarian cysts the current recommendation is conservative 




Dekel et al reported a study consisting of 2.561 women with hysterectomy and ovarian 
preservation that after 20yrs of follow-up only 2.8% required subsequent oophorectomy 
[9]
. 
This therefore illustrates that the small percentage for repeat surgery does not warrant the 




1.2.3   Prevention of breast cancer 
 Approximately 10% of all diagnosed cases of breast cancers are familial, and is   identified 
in younger females with an increased risk of bilateral disease and strong association with 
BRCA1 and BRCA2 genes. Women who have mutations of BRCA1 have a lifetime breast 
cancer risk estimated at 54% and with BRCA2 mutations there is a risk of 23% 
[11]
. The 
general population will have approximately 0.1-0.2% risk of BRCA mutations, while the rate 
is much higher in patients of Ashkenazi Jewish ancestry, which is approximately 2%.  
Patients who have positive tests for deleterious mutations can be considered for prophylactic 
surgery. Kauff et al conducted a prospective study in order to evaluate whether 
premenopausal prophylactic oophorectomy was efficient in reducing the incidence of breast 
cancer. In the study women who had not undergone mastectomy before enrolment were 
chosen for evaluation.  In the surveillance group there were eight patients who had breast 
cancer versus 3 patients in the PO group (P = .07). The estimated amount of patients who 
were  both free of ovarian and breast cancer at 5 years was substantially higher in the PO 
group (P = .006), with a hazard ratio of 0.25 for the development of either ovarian or breast 
cancer[1]. Breast cancer incidence is related to age, increasing at forty and fifty years of age 
and then continuing to rise but not as severely post menopause. Therefore   endogenous sex 
hormones have been implicated in its development 
[12] . I
n patients who are 50yrs and younger 
undergoing oophorectomy a reduced risk in breast cancer has been reported. This reduced 
risk can be attributed to the decreased exposure of oestrogen.  In patients older than 50yrs 
who have undergone an oophorectomy no benefit has been reported in breast cancer 
reduction. The NURSES HEALTH STUDY reported a reduction in breast cancer incidence 
in patients who had undergone an oophorectomy at 45yrs or less and not in other age groups 




1.3 Disadvantages of Oophorectomy 
Premenopausal oophorectomy results in loss of cyclic ovarian hormone secretion, this results 
in both vasomotor symptoms ( E.g. vaginal dryness ) and other consequences of oestrogen 
deficiencies (e.g. hip fractures and osteoporosis). Oestrogen is important for bone 
remodelling, vascular integrity and for metabolism of lipids. Oestrogen is an important 
hormone, produced in the ovaries. It is present in its natural form as a steroid hormone and 
14 
 
occurs in three forms namely oestrone, oestradiol and oestriol. During the reproductive years 
of a female oestradiol is the predominant hormone while oestrone is the primary oestrogen 
hormone during the menopausal period. (FSH)  stimulates the granulosa cells on the ovarian 
follicles to produce oestrogen. However oestrogen is also produced in secondary sites 
including liver, breast and fat cells. This secondary source of oestrogen is important for the 
menopausal female as ovaries decline in their function of producing oestrogen.  
During puberty oestrogen plays a vital role in secondary sexual characteristics. In the adult 
female it enhances growth of the endometrium, vaginal lubrication, ovulation and plays an 
important role in the female sex drive. Oestrogen is also important for the growth of new 
bone and reduces bone resorption. It has also been noted to reduce fat deposition and increase 
(HDL).  Oestrogen is vital for mental health, with low levels of oestrogen correlating to low 
moods. Douma et al found that oestrogen played a vital role in stabilizing depressive 
symptoms in premenopausal and postmenopausal females
[13]
. 
 Thus the positive effects of physiological oestrogen and the prevention of an early surgical 
menopause remains a strong argument for ovarian conservation. 
 
1.3.1 Cardiovascular disease 
Prophylactic oophorectomy performed during hysterectomy for benign conditions has been 
associated with loss of ovarian sex steroid hormones as a result of the surgical menopause 
that ensues. Natural menopause usually occurs around the ages of 45 to 55 years it is a 
gradual process which is associated with menstrual irregularities. In surgical menopause 
patients are usually younger and experience effects of oestrogen deficiency suddenly and they 
are usually noted soon after removal of the ovaries. Long term effects of oestrogen deficiency 
can lead to increased risk of cardiovascular disease 
[14]
. 
Menopausal women have been noted to have higher levels of serum lipids and plasma 
fibrinogen profiles which predispose them to cardiovascular disease. Low levels of 
endogenous oestrogens during the menopausal period causes higher levels of low – density 
lipoproteins which together with smoking and hypertension greatly increase the risk of 
cardiovascular disease.  Several studies have shown an association of prophylactic 
oophorectomy with coronary heart disease 
[15, 16]
. The Nurse‟s Health Study found a 
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significant increase in coronary heart disease in patients who underwent oophorectomy (207 
versus 163 per 100,000 person years; HR 1.17, 95% CI 1.02-1.35) 
[3]
. 
This can be expressed as one extra death from coronary heart disease for every 130 women 
who have undergone bilateral oophorectomy. However the risk of developing cardiovascular 
disease is controversial and has been based on observational data only. A subset analysis 




In contrast the Women‟s Health Initiative Observational Study found no significant 
association between oophorectomy and coronary heart disease (380 versus 353 per 100,000 
person-years; HR 1.00, 0.85-1.18  Metabolic diseases (e.g. type 2 diabetes) and  
dyslipidaemias have been noted to be more prevalent in postmenopausal  than in 
premenopausal females. These conditions are important risk factors for cardiovascular 
disease. 
 
1.3.2 Osteoporosis/hip fractures 
Osteoporosis is a skeletal disease characterised by low bone mass, changes in the micro- 
architecture and breakdown in the remodelling of the bone. Oestrogen is essential for new 
bone formation. Both osteoblasts and osteoclasts have oestrogen receptors. Oestrogen inhibits 
lysosomal enzyme production thereby decreasing bone resorption and causes osteoblasts to 
produce cytokines which inhibit osteoclast activity. Osteoporosis is commonly seen affecting 
cancellous bone with increased fractures noted over the vertebrae and proximal femur. 
 Oophorectomy is associated with a significant risk for the formation of osteoporosis, 
especially if it occurs before the age of 45yrs. Early menopause and oophorectomies have 
been associated with lower bone density which is associated with a higher fracture rate
[17]
. 
Oestrogens and androgens play a role as inhibitors of bone resorption and surgical 
menopause has been associated with decreased levels of endogenous oestrogens and 
androgens. One study which evaluated 340 women where a prophylactic oophorectomy was 
performed at a median age of 62yrs, over a period of 16 years, reported a 54% higher risk of 
osteoporotic fractures than females who retained their ovaries 
[18].
 In patients greater than 60 
years of age where oophorectomy had been performed, there was a two-fold risk of death 
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following a low-trauma hip fracture, compared to women who had intact ovaries (odds ratio 




1.3.3 Cognitive function 
Dementia and depression have been associated with oophorectomy. The Mayo Clinic Cohort 
Study of Oophorectomy and Aging found that when oophorectomy was performed prior to 
the start of menopause there was an increased risk for the development of dementia, anxiety, 
depression and parkinsonism. 
 
The Women‟s Health Initiative study found that patients older 
than 65 years  who were either treated with only oestrogen or a combination of oestrogen and 
progestin , had a higher risk for cognitive impairment and dementia 
[19]
. The findings of the 
study show us that oestrogen might have a protective function if it is administered soon after 
menopause and might be harmful if administered many years after menopause
[20]
. Multiple 
studies have shown that endogenous ovarian hormones are important for brain integrity 
[20, 21]
. 









1.3.4 Mental Health and Sexual Function 
Endogenous androgens produced in the ovarian stroma have been noted to play a key role in 
the female sexual drive. Oophorectomies in premenopausal females result in decreased 
endogenous androgens this has been suggested as a causal factor in decreased libido. Studies 
have shown that women who have had BSO reported sexual dysfunction than women with 
retained ovaries, and their symptoms have not improved with oestrogen therapy 
[25, 26]
.                                              
Madalinska and colleagues  found that in females who underwent prophylactic oophorectomy 
there was a higher risk for decreased sexual satisfaction and dyspareunia than with females 




In the premenopausal women oophorectomy causes a sudden loss of oestrogen and over time, 
there is vaginal dryness, loss of orgasm, decreased libido and sexual dysfunction. This is 
associated with feelings of decreased self-worth and a negative image. In a prospective study 
involving 101 women, females who had oophorectomy together with hysterectomy were 
found to be more anxious and depressed and had a lower positive well-being than females 
who underwent hysterectomy alone 
[25]
.  A study involving European patients with low risk 
for cancer found that females who underwent BSO had a double risk of developing 
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hypoactive sexual desire syndrome as compared to patients who were premenopausal or 




1.4 Statement of the Problem 
There are few guidelines that stipulate exact criteria for oophorectomy at the time of surgery,   
especially in females with no familial risk for ovarian, breast and colon cancer. In most 
countries the decision for prophylactic oophorectomies   lies with the gynaecologist, hence 
the decision for our study arose from the need for proper guidelines to identify which patients 






Chapter Two - Methodology 
 
2.1 Objectives 
1. To identify local practice of prophylactic oophorectomy at the time of hysterectomy. 
2. To identify which conditions would favour ovarian preservation versus those which 
would support oophorectomy. 
3. To identify which guidelines gynaecologists, registrars and medical officers practice.  
4. To assess the need for local guidelines on prophylactic oophorectomy at the time of 
hysterectomy for benign disease. 
5. To assess if differences in practices exist between different groups (public, private 
consultants, senior registrars, medical officers, male and females).  
2.2 Research design 
This was a descriptive study using questionnaire surveys. 
2.3 Study population 
Medical doctors with interest in obstetrics and gynaecology were approached at the 
SASOG (South African Society of Obstetricians and Gynaecologists) May 2012 
conference. 
2.4 Sampling and Data collection 
Since this is a descriptive study, the power of the study is not considered in sample 
size calculation. Rather the precision that the sample size will provide to estimate a 
given parameter of the population. Since many parameters are being investigated, it 
was decided the sample size should be decided on logistical and time constraints 
rather than statistical validity. 
2.5 Inclusion and exclusion criteria 
2.5.1 Inclusion criteria 
Gynaecology registrars, medical officers and gynaecologists who attended the 
SASOG meeting in Drakensberg May 2012. 
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2.5.2 Exclusion criteria 
Nonmedical personnel and those not involved in obstetrics and gynaecology. 
2.6 Data collection and methods 
Descriptive study that was presented as a questionnaire to medical doctors practising 
in obstetrics and gynaecology at the SASOG conference in Drakensberg (May 2012) 
2.7 Data analysis 
The data collected will be captured and subsequently analysed using the Statistical Package 
for Social Sciences (SPSS version 19). Descriptive statistics such as mean, standard 
deviation, frequencies and percentages will be used to summarize results. Pearson Chi-square 
test or Fisher‟s exact test will be used to test for association level of experience and current 
practice. Two independent samples test or Mann Whitney test will be used to test if there is 
any relationship between current practice and age of the practitioner.  
2.8 Ethical consideration 
The study was approved by the Biomedical Research Ethics and Postgraduate Committees of the 
University of KwaZulu Natal. This was a descriptive study where patient‟s confidentiality was 
maintained, case numbers instead of patients names were used as identification. All principles of 
the Declaration of Helsinki were upheld. Ethics number REF: BE 087/12 (Appendices 2 and 3 for 











Chapter Three - Results 
3.1 Age 
One hundred and eighty five participants took part in this questionnaire based study. The 
mean (range) age of the participants was 46 ± 8.2 (range: 28-75) years.  The participants were 
either specialist (n=147), registrar (n=35) or medical officer (n=3). The mean (SD) age of the 
specialists was 47.9 ± 14.2 years and the mean (range) number of months since being 
qualified as was a specialist was 16 (1-146) months The mean (SD) of the registrars was 51.6 
± 14.7 years and the mean (range) number of years in training 3 (1-5) years. The mean (SD) 
age of the medical officers was 48.3 ± 2.9 years.  There was no difference in age between the 
participants (p=0.3). The age groups of the participants were as follows: 20-30 (n=6; 3%); 
31- 40 (n= 60; 32%; 41-50 (n=58; 31%); 51-60 (n=42; 23%) and >60 (n=19; 10%) and is 




































One hundred and twelve (71%) of participants were male and the remaining 73 (29%) were 











Figure 2:  Sex of participants 
3.3 Province of medical practice 
Thirty sixty (19%) of the participants practiced in Gauteng followed by Western Province 22 
(12%), KwaZulu Natal 12 (6%), Orange Free State 9 (5%), Mpumalanga 6 (3%), Northern 
Province 4 (2%), Eastern Province, Northern Cape and others (USA (n=2) and Nairobi) 
































3.4 Type of practice 
Eighty eight (48%) were practicing in private, 71 (38%) were practicing in the public sector 
while 36 (14%) were practicing in both private and public sector. Where the participants are 








Figure 4: Type of practice 
3.5 Level of experience 
Among the participants there were 147 (79%) specialist, 35 (19%) registrars and 3 (2%) were 



















Type of Practice of Participants 
Private  sector Public  sector Public and private sector
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3.6 Place of postgraduate training 
Majority of the participants did their postgraduate training in University of Stellenbosch 
(n=41; 22%); followed by 37 (20%) at University of Pretoria; 30 (16%) at University of 
Witwatersrand; 25 (14%) at University of Free State and University of KwaZulu Natal; 11 
(6%) at University of Cape Town; 7 (4%) at Medunsa; 3 (2%) Limpopo University, Walter 
Sisulu University and Others (USA (n=2); Nairobi (n=3)). 








Figure 6:  Place of postgraduate training of participants 
3.7 Year of graduation 
Majority (90%) of the participants graduated between the years 1980-2000. The year of 
graduation of the participants are listed in Table 1. 




   
 













































Figure 7: Shows year of graduation 
3.8 At what age do you recommend your patients to have prophylactic 
oophorectomy following hysterectomy for benign conditions? 
The mean (SD + range) age at which specialists, registrars and medical officers  recommend 
patients to have prophylactic oophorectomy following hysterectomy for benign conditions 
was 52.18  ±4.7 (35-65); 54.49±5.3 and 55 ±3.9 years respectively. There was no difference 
between specialists, registrars and medical officers with regards to age at they recommend 
patients to have prophylactic oophorectomy following hysterectomy for benign conditions 
(p=0.45). 
3.9 Which factors would strongly influence your decision other than age to 
do prophylactic oophorectomy at the time of hysterectomy for benign 
disease? 
Table 2 depicts factors other than age influencing the decision of specialists, registrars and 
medical officers when performing bilateral oophorectomy at hysterectomy for non-malignant 
disease. Familial history of ovarian, breast or colon cancer (94%) was the commonest factor 
followed by patient‟s choice (48%), presence of ovarian cysts (45%), presence of 
endometriosis (37%), presence of peri-menopausal symptoms (35%), follicle stimulating 
hormone > 10 (17%) and other reasons (10%). A number of participants listed multiple 
factors of which familial history of ovarian, breast or colon cancer, presence of ovarian cysts 
















Table 2: Factors influencing decision other than age for prophylactic oophorectomy at 
the time of hysterectomy for benign disease 
  
3.10 Are you aware about the WHI study on HRT? 
One hundred and eighty (97%) of the participants were aware of WHI study on HRT. Five 
(3%) did not know about the WHI study on HRT  
   
3.11 Has the results of WHI study on HRT changed your practice of 
prophylactic oophorectomy following hysterectomy for benign conditions? 
Two hundred and two (81%) of the participants indicated that they benefitted after reading 
the results of the WHI study on HRT and subsequently changed their practice of prophylactic 
oophorectomy following hysterectomy for benign conditions. In 35 (14%) participants, the 
results of the WHI study on HRT did not affect their practice. A very small percentage (6%) 
of the academics did not respond to this question. 
In 129 (64%) of the 202 participants stated that after reading the WHI results they would 
delay the unnecessary prescribing and the use of HRT.   Sixty (30%) of the 202 participants 
stated the WHI results prevented them from doing unnecessary surgery. The analysis of data 
of this question is shown in Table 3 and is illustrated graphically in Figure 8. 
 
 
Variable Number Percentage 
Familial history of breast/ovarian/colon cancer 
Follicle stimulating hormone > 10 
Presence of peri-menopausal symptoms 
Presence of ovarian cysts 
Presence of endometriosis 
Patience choice 

















Table 3:  Outcomes of the results based on the WHI study on HRT 
Variable Number % 
Delay in the use of HRT 










Figure 8: Outcomes of results based on WHI study 
3.12 Aware of current guidelines (local/international) 
All the participants were aware of both local and international guidelines. International 
guidelines namely American College of Obstetrics and Gynaecology (ACOG), Royal College 
of Obstetrics and Gynaecology (RCOG) and Royal Australian and New Zealand College of 
Obstetrics and Gynaecology (RANZCOG) were well known to the participants. Source of 







Outcome Of Results Based On The WHI Study 
Delay in use of HRT Prevents unnecessay surgery Others
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Chapter Four - Discussion 
Prophylactic oophorectomy was generally performed together with an elective 
hysterectomy for women greater than the age of 50 years as it was believed that this would 
decrease the patient‟s risk of subsequent development of ovarian cysts, carcinomas and 
repeat surgeries.  
The decision to perform oophorectomy in conjunction with hysterectomy for benign 
conditions is often made by the attending gynaecologist. The results from this study 
showed that prophylactic oophorectomy was being performed on patients greater than 50 
years of age. The Royal Australian and New Zealand College of Obstetricians and 
Gynaecologists published a statement as follows: “when hysterectomy is performed in 
patients less than 65 years for benign gynaecological disease careful consideration should 
be made when bilateral oophorectomy is being performed.”
[5].
 Prophylactic oophorectomy 
performed in the premenopausal female has been associated with a higher incidence of 
osteoporosis and hip fracture
,[29]
  cognitive impairment 
[30],
 and cardiovascular mortality 
[31]
. 
Patients who developed surgical menopause were started on HRT to help relieve vasomotor 
symptoms such as hot flushes. The WHI Study however indicated that women who 
received hormone replacement had a significant risk of developing cardiac disease and 
strokes. 81% of the participants from this study stated that they had benefitted from the 
WHI study and 64% had delayed the premature administration of HRT.  A separate 
analysis in the Nurse‟s Health Study analysed women who never utilized postmenopausal 
HRT.  It showed that women who had a bilateral oophorectomy had a higher risk of stroke 
(HR, 1.85; 95% CI, 1.09, 3.16) than women who had conserved their ovaries. Amongst the 
women where oophorectomy was performed before 50 years and were HRT was not 
utilized, the risk of CAD was higher (HR, 1.98; 95% CI, 1.18, 3.32) 
[14].
  The rates of usage 
of oestrogen continue to decline amongst women with bilateral oophorectomy 
[31]
 , despite 
the positive benefits of the hormone in patients who have undergone BSO. After 6 months 
following the introduction of the Women‟s Health Initiative study on oestrogen–progestin 
therapy, it was found that oestrogen replacement reduced from 12.6% to 9.1% 
[31]
. The 
results from this study state that 97% of participants were aware of the WHI study and that 
64% would delay the unnecessary administration of HRT to patients following outcomes 




Participants in this study were aware about local and international guidelines available 
(table 4) however 41% did not utilize the guidelines to make informed decisions. Instead 
they used the family history of cancer and the age of the patient as a guide to decide on 
surgery, 38% used international guidelines, 9% utilized departmental guidelines and 10% 
used their own discretion and experience to make a decision. Factors that strongly 
influenced the decision for prophylactic oophorectomy other than age were as follows:  
family history of ovarian breast and colon cancer (94%) followed by patient‟s choice 
(48%), presence of ovarian cysts (45%), presence of endometriosis (37%), presence of peri-
menopausal symptoms (35%), follicle stimulating hormone > 10 (17%) and other reasons 
(10%) (table2). A number of participants listed multiple factors of which familial history of 
ovarian, breast and colon cancer, presence of ovarian cysts and presence of endometriosis 
being strong motivation for BSO. The participants in this study favoured oophorectomy 
especially with regards to age greater than 50 years with a familial history of cancer and 
patients who requested removal of the ovaries. 
 
Conservative management in patients greater than 50 years was not done as patients 
requested surgical intervention as to prevent cancer and future surgical interventions. The 
majority of the participants (85%) indicated the need for local guidelines to allow for 
uniformity of diagnosis, clear decision making, to guide practices, and to prevent medico-
legal issues and unnecessary surgery. There was no difference between specialists, 
registrars and medical officers with regards to age at which they recommended patients to 
have prophylactic oophorectomy, when hysterectomy was performed for benign conditions. 
 
Prophylactic oophorectomy has been shown to be beneficial in patients with BRCA1 and 
BRCA2 genes in order to prevent the development of breast and ovarian cancer however in 
low risk females with no family history of cancer it has been linked with a high risk of 
morbidity and mortality. The dilemma at present is that:  
1. Should all women with low risk for ovarian cancer be offered prophylactic 
oophorectomy? 
2.  What is the ideal age to perform bilateral oophorectomy in high risk women? 
 
The results from this study identify prophylactic oophorectomy as the treatment of choice 
for patients greater than the age of 50 years with benign gynaecological conditions. This 
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practice is not in keeping with the RANZOG statement on exercising caution in performing 
bilateral oophorectomy in patients younger than 65yrs with benign disease. In the United 
States of America, 40% of hysterectomies for non-malignant conditions are accompanied 
with BSO when performed among patients aged 40–44 years; in 60%, among patients aged 
45–50 years; and in 78%, among patients aged 50–55 years
[32]
 . The recommended age of 
prophylactic oophorectomy of 50years as recommended by this study is also partially 
supported by two studies conducted in the United Kingdom by Jacobs et al 
[33] 
and in Italy 
by Mezzapane et al 
[34]
 which reported approximately 20% of gynaecologists who routinely 
perform prophylactic oophorectomies for patients aging between 45-50 years. 48% of 
participants felt that patient choice was a strong reason to decide on surgery and not 
conservative management. This decision should however only be done with patients 
assessed on an individual basis with their gynaecologist. Careful attention should be made 
especially to benefits and disadvantages of prophylactic oophorectomy for benign 
conditions.  
 
Majority of the participants in this study were males (71%), specialist gynaecologists 
(79%) and working in the private sector. However with regards to decision for prophylactic 
oophorectomy, there was uniform consensus amongst participants. There was a 
discrepancy in the ratio of male to female participants, therefore this study was unable to 
determine whether a difference of practice exists with the different sexes. The results from 
this study show that irrespective of the years of experience of the gynaecologist (figure 5), 
or university in which post-graduate teaching was accomplished the participants, still 
performed prophylactic oophorectomy in patients older than 50 years. 
 
The recommendation from this study is that patients who are more than 50 years should 
have an oophorectomy together with hysterectomy for benign gynaecological conditions. 
This is strongly supported especially in patients who have a family history of either breast 
and/or ovarian cancer. This study also recommends that guidelines be made available in 
order to assist the gynaecologist as well as the patient in making an informed decision with 
regards to surgery. 
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4.1 Limitations of the study 
The study was conducted at an Obstetrics and Gynaecology conference with a select amount 
of participants as such a limited number of doctors were present and majority of the medical 
doctors were specialists from the private sector. 
4.2 Conclusion and Recommendations 
As evident by the responses received in the questionnaire the majority of doctors (85%) felt 
that there was a need for guidelines to be set out in order to direct obstetricians and 
gynaecologists in making uniform decisions and to prevent unnecessary surgery. Seventy six 
(41%) of the participants did not use any guidelines but used the familial history of cancer 
and the age of the patient as a guide to decide about surgery. Sixty nine (38%) were using 
international guidelines.  Sixteen (9%) used departmental guidelines while 19 (10%) used 
their experience to decide. 
Factors that influenced specialists, medical officers and registrars to opt for prophylactic 
oophorectomy at the time of hysterectomy included family history of ovarian/breast/colon 
cancer (94%) followed by patients choice (48%), presence of ovarian cysts (45%), presence 
of endometriosis (37%), presence of peri-menopausal symptoms (35%), follicle stimulating 
hormone > 10 (17%) and other reasons (10%). There was no difference between specialists, 
registrars and medical officers with regards to age of more than 50 years at which they 
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Study: Prophylactic oophorectomy at the time of hysterectomy for benign disease 
Questionnaire number:  
A) Personal Details (tick appropriate box) 
 
1) Age  
 
 
2) Sex   
Male female 
   
3) Province of medical practice  
Eastern Cape Mpumalanga  
Western Cape Gauteng 
Northern Cape Free State 
Northern Province North West 
Kwazulu Natal Other 
 
 
4) Type of Practice 
  Private practise  
  Public sectors  




5) Level of experience 
Specialist  
Registrar  
Medical officer  
 
6) Place of post graduate training ( if applicable)  
University of Kwa-Zulu Natal  
University of Pretoria  
University of Cape Town  
University of Bloemfontein  
University of Stellenbosch  
Walter Sisulu University  
Limpopo University  
Medical University of South Africa  
Other  
 




B) Level of experience ( tick appropriate box) 
8) If specialist 





9) If  Registrar  
   Number of years of training. 
 
 
10) If Medical Officer 
Number of years of training  
 
a) Have you previously trained  as a registrar in obstetrics and gynaecology 
Yes No 
 
b) If yes, state the number of years 
 
 
C) Factors influencing decision for prophylactic oophorectomy  
11)  At what age do you recommend your patients to have prophylactic oophorectomy following 
hysterectomy for benign conditions :  
 
 
12) Which factors listed  below would  strongly influence your decision other than age to do 
prophylactic oophorectomy at the time of hysterectomy for benign disease:  
1) Fami family history of ovarian/breast/colon cancer  
2) Folli  follicle stimulating hormone > 10  
3) Prese presence  of peri-menopausal symptoms  
4) Preso presence of ovarian cysts  
5) Prese presence of endometriosis  
6) Patie  patient choice  










14) Has the results of WHI study on HRT changed your practice of  prophylactic oophorectomy 









D) Guidelines (tick appropriate box) 
16)  Are you aware of current guidelines (local / international) for prophylactic oophorectomy at 
the time of hysterectomy for benign conditions? 
yes no 
 









18) Do you think there is a need for local guidelines on prophylactic oophorectomy at the time of 






19) What guidelines are you currently using in determining which patients are suitable for 
prophylactic oophorectomy? 
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Appendix 4 
